Trinity Biotech Plc (TRIB)
0.666
-0.01
(-2.06%)
USD |
NASDAQ |
Jun 09, 10:22
Trinity Biotech SG&A Expense (Quarterly) : 7.304M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amarin Corp. Plc | 19.35M |
| Grifols SA | 328.75M |
| Cellectis SA | 5.610M |
| Akari Therapeutics Plc | 2.165M |
| Autolus Therapeutics Plc | 39.89M |